Eikon Therapeutics has appointed Ma. Fatima D. Francisco as an independent director on its Board, effective June 15, 2026. Francisco brings extensive leadership experience from Procter & Gamble and will also join the Compensation Committee. Her expertise in commercial planning and innovation is expected to support Eikon's growth as it develops new medicines for serious medical needs, particularly in oncology. This move strengthens Eikon's leadership as it advances its drug pipeline and global operations.
The global reactive hot melt adhesives market is projected to grow from $2.02 billion in 2025 to $4.29 billion by 2035, at a CAGR of 7.72%. Growth is driven by regulations limiting solvent-based adhesives, increased use of polyurethane adhesives in a...
Wendy's is running a $1 promotion on small Classic Chocolate or Vanilla Frosty from July 20 to August 23, with early access for Wendy's Rewards members on July 19 in celebration of National Ice Cream Day. The offer is redeemable via the Wendy's app a...
Dyadic International has expanded its bio-industrial pipeline with a new proprietary enzyme program focused on advanced cellulose processing, building on the success of its EN3ZYME™ product. This initiative leverages Dyadic's Dapibus™ platform to str...
Forum Markets has acquired a commercial aircraft engine for about $12 million, increasing its aviation portfolio to four engines leased to major U.S. airlines. The engine, a widely used CFM56-7B model, is already generating revenue under a long-term ...
The award-winning faith-based film 'Our Crossroads,' based on a true story of a young couple caring for orphaned siblings in 1969 Ohio, premiered exclusively on the Angel streaming platform on July 16, 2026. The film, which won Best Faith/Family Feat...
